Neurogen News

Neurogen Corp. has laid off half of its already shriveled workforce and is taking steps to sell itself, the Branford drug development company said Tuesday.

Neurogen Corp., a pioneering member of Connecticut's small but lively biotech industry, has hired an adviser to help sell the company or its assets and has laid off half of its already shriveled workforce, the company said Tuesday.

May 12, 2009 - Neurogen Corporation , a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced financial results for the quarter ended March 31, 2009.

PennyStockChaser.com is pleased to offer a hot stock alerts service. Investors can receive FREE Stock Alerts by visiting the following link: http://www.pennystockchaser.com/join-now/ Today's news alerts include: Neurogen Corporation Announces Webcast of First Quarter 2009 Financial Results on May 12, 2009 BRANFORD, Conn., May 08, 2009 -- Neurogen ...

As Agent Bank, please be advised of the following rate determined on: 08/05/09 Issue General Electric Capital Corporation - Series 4773 - JPY 10,000,000,000 FRN due 12 May 2010 - SALT LAKE CITY-- --USANA Health Sciences, Inc.

This report is an update to a previous version and is updated to 24th April 2009.

William Koster was appointed managing director of the Boston office of Loree Newmyer Sulkowicz LLC , an executive search firm heaquartered in New York City.

Hubbell Inc., a manufacturer based in Orange, will combine its wiring and electrical products divisions, and Neurogen Corp., a drug development company in Branford, has agreed to sell one of its patents, in ...

BRANFORD, Conn.-- --Neurogen Corporation , a drug development company focused on improved drugs for psychiatric and neurological disorders, today announced it has entered into a definitive - DALLAS-- --DRI ...